Pharma Focus Asia
Webinar Sponsored by



The future of titanium dioxide in pharma

An ACG 360 webinar series.

The future of solid dosage. From formulation to commercialisation.

Tomorrow’s oral solid dosage will be shaped by how you manufacture today. So are you adopting new technologies, and reimagining old ones?

New times call for new ways of thinking, so with this in mind you’ll need to:

  • Design patient-centric formulations and packaging
  • create processes that guarantee quality
  • improve operational agility continuously to ensure faster speed-to-market
  • respond smartly to escalating market demand
  • all of the above, while also remaining cost-effective.

Join us to find out more about staying competitive in an increasingly complex market, and to discover new opportunities for co-creating with us.

This webinar is part of ‘The future of solid dosage’, an ACG 360 webinar series covering wide-ranging, simple and transformative ways to achieve smarter pharma formulation, manufacture and packaging.

We’re sharing the industry’s most comprehensive and holistic view… as only we can.


David R. Schoneker

David R. Schoneker

President, Black Diamond Regulatory Consulting, LLC

About - David R. Schoneker

David R. Schoneker is currently the President and owner of Black Diamond Regulatory Consulting, LLC, a consulting firm specialising in providing regulatory and quality consulting for the pharmaceutical, dietary supplement, food and related industries. With over 45 years of experience working in these areas, Dave has developed strong networks with trade associations, regulatory agencies and pharmacopeias around the world. He is also an Adjunct Professor at Temple University's School of Pharmacy in their RA/QA master's programme. Prior to August 2019, David R. Schoneker was the Global Regulatory Director – Strategic Relationships at Colorcon, Inc. His responsibilities included global coordination of Colorcon’s worldwide regulatory activities. He is currently a member of the Executive Committee, the Chair of the QbD/Composition Committee.

Simon Roberts

Simon Roberts

PhD, CChem, CSci, MRSC

Scientific Business Development Manager (Europe)

About - Simon Roberts

Simon has a BSc in Chemistry from Durham University and a PhD in Biopolymer Mixtures from Cranfield University. He then undertook postdoctoral positions at the University of Cambridge, Queen Mary University of London and UCL School of Pharmacy. On leaving academia he joined Lipoxen as a research scientist developing therapeutic protein- polysaccharide conjugates. This was followed by five years working as a Senior Scientist at Abbott Laboratories in the global oral drug products group. He then moved in to a commercial role and spent ten years as the Pharmaceutical Sales Manager for Ashland Specialty Ingredients with responsibility for the UK & Ireland. Before joining ACG in March 2022 he held the position of Pharmaceutical Sales Manager for Barentz UK. He is a Chartered Chemist, Chartered Scientist and Member of the Royal Society of Chemistry and also a member of the Academy of Pharmaceutical Sciences for which he is the co-chair of the Material Science Focus Group.